Back |
home / stock / poai / poai message board
Subject | By | Source | When |
---|---|---|---|
NetworkNewsWire: NetworkNewsBreaks Predictive Oncology Inc. (NASDAQ: POAI) Eyes Expansion of AI-Dri | NetworkNewsWire | investorshangout | 04/09/2021 7:37:24 PM |
jonny red32: POAI Update: StockCast | Premarket stock overview 4/9/2021 | Stocks to Buy In April 202 | jonny_red32 | investorshangout | 04/09/2021 12:00:52 PM |
NetworkNewsWire: Predictive Oncology Inc. (NASDAQ: POAI) Taps Its Chairman to be CEO - Current POAI | NetworkNewsWire | investorshangout | 04/05/2021 7:58:56 PM |
znewcar1: Was SKLN & AIPT before POAI 25% 4M C$1.01 midmorn spike04/04/2018 POAI 22% v2,05M c1.8 | znewcar1 | investorshangout | 04/03/2021 4:40:47 AM |
znewcar1: POAI 21% v3,8M c1.47 f48,7M H1.48 | znewcar1 | investorshangout | 04/02/2021 3:09:58 AM |
News, Short Squeeze, Breakout and More Instantly...
Predictive Oncology Inc. Company Name:
POAI Stock Symbol:
NASDAQ Market:
Predictive Oncology Inc. Website:
Predictive Oncology (NASDAQ: POAI) , a leader in AI-driven drug discovery and biologics, today announced the introduction of a new technology designed to express functional and stable G-Protein Coupled Receptors (“GPCRs”). GPCRs are cell surface membrane receptors believed to play a...
Company files expansive intellectual property protection for “Membrane Protein Factory” to produce purified and biologically active membrane proteins for drug development External sources value annual US GPCR market at nearly $3.5 billion in 2022, growing more than 5% annu...
Predictive Oncology (NASDAQ: POAI) , a leader in AI-driven drug discovery and biologics, today announced the availability of its unique 3D cell culture model to advance cancer drug discovery and enable future drug development. More closely mimicking human tissue architecture than traditional 2D a...